ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 491

$1.25M Total Retail Price of All Prescriptions

Rank: 21 out of 491

678 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 678 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

23% of this provider’s 678 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

5% of this provider’s 3,742 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$158 was the average price of a prescription from this provider, compared to $218 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 839 320 S3 1 6
GABAPENTIN 528 246 2 1
LEVETIRACETAM 299 140 3 5
CARISOPRODOL 223 48 R 4 24
CITALOPRAM HBR 184 122 5 18
TIZANIDINE HCL 173 44 6 20
NAMENDA 167 161 7 4
AMITRIPTYLINE HCL 156 68 R 8 14
EXELON 151 126 9 12
TRAMADOL HCL 147 81 10 27
TRAZODONE HCL 145 93 11 31
TOPIRAMATE 139 31 12 7
BACLOFEN 129 14 13 21
DIVALPROEX SODIUM 119 38 14 40
LYRICA 117 50 15 10
ROPINIROLE HCL 117 65 15 9
CLOPIDOGREL 114 95 17 33
VIMPAT 111 0 18 19
MORPHINE SULFATE ER 107 20 S2 19 45
VENLAFAXINE HCL ER 102 45 20 47
PLAVIX 98 89 21 41
PRIMIDONE 94 53 22 11
ZOLPIDEM TARTRATE 94 41 22 28
DIVALPROEX SODIUM ER 90 49 24 29
OXCARBAZEPINE 88 12 25 26
LISINOPRIL 87 21 26 56
CARBIDOPA-LEVODOPA 85 85 27 2
NORTRIPTYLINE HCL 82 48 28 32
WARFARIN SODIUM 72 44 29 73
CYMBALTA 69 19 30 13
DONEPEZIL HCL 68 68 31 3
CYCLOBENZAPRINE HCL 68 33 R 31 43
QUETIAPINE FUMARATE 64 16 33 34
LAMOTRIGINE 61 0 34 8
COPAXONE 59 0 35 39
MELOXICAM 57 33 36 37
REQUIP XL 55 35 37 100
PRAMIPEXOLE DIHYDROCHLORIDE 55 50 37 15
OXYCONTIN 55 14 S2 37 67
AGGRENOX 53 32 40 44
SIMVASTATIN 52 32 41 65
LEVOTHYROXINE SODIUM 50 0 42 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.